Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (AU2016250100) Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions

Office : Australia
Application Number: 2016250100 Application Date: 13.04.2016
Publication Number: 2016250100 Publication Date: 20.10.2016
Publication Kind : A1
Prior PCT appl.: Application Number:US2016027355 ; Publication Number: Click to see the data
IPC:
A61K 35/74
A61K 35/741
A61P 1/00
G06F 19/12
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
66
Materials from micro-organisms
74
Bacteria
[IPC code unknown for A61K 35/741]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1
Drugs for disorders of the alimentary tract or the digestive system
G PHYSICS
06
COMPUTING; CALCULATING; COUNTING
F
ELECTRIC DIGITAL DATA PROCESSING
19
Digital computing or data processing equipment or methods, specially adapted for specific applications
10
Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
12
for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
Applicants: Ubiome, Inc.
Inventors:
Agents: Clark Intellectual Property Pty Ltd
Priority Data: 62/146,789 13.04.2015 US
62/147,083 14.04.2015 US
Title: (EN) Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
Abstract: front page image
(EN) A method for at least one of characterizing, diagnosing, and treating a cutaneous condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the cutaneous condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the cutaneous condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.